Free Trial

Strata Critical Medical (SRTA) Competitors

$4.82 -0.08 (-1.63%)
Closing price 04:00 PM Eastern
Extended Trading
$4.84 +0.01 (+0.31%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SRTA vs. LPG, VTOL, GSL, NVGS, and CCEC

Should you be buying Strata Critical Medical stock or one of its competitors? The main competitors of Strata Critical Medical include Dorian LPG (LPG), Bristow Group (VTOL), Global Ship Lease (GSL), Navigator (NVGS), and Capital Clean Energy Carriers (CCEC). These companies are all part of the "transportation" industry.

How does Strata Critical Medical compare to Dorian LPG?

Dorian LPG (NYSE:LPG) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap transportation companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

62.5% of Dorian LPG shares are owned by institutional investors. Comparatively, 47.4% of Strata Critical Medical shares are owned by institutional investors. 13.6% of Dorian LPG shares are owned by insiders. Comparatively, 15.5% of Strata Critical Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Dorian LPG has a net margin of 29.88% compared to Strata Critical Medical's net margin of 20.97%. Dorian LPG's return on equity of 11.82% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Dorian LPG29.88% 11.82% 7.06%
Strata Critical Medical 20.97%-5.92%-5.09%

Dorian LPG has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Dorian LPG, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dorian LPG$404.13M4.23$90.17M$2.8414.09
Strata Critical Medical$197.14M2.13$41.35M$0.499.84

In the previous week, Dorian LPG had 2 more articles in the media than Strata Critical Medical. MarketBeat recorded 3 mentions for Dorian LPG and 1 mentions for Strata Critical Medical. Dorian LPG's average media sentiment score of 0.39 beat Strata Critical Medical's score of 0.00 indicating that Dorian LPG is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Dorian LPG
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Strata Critical Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Dorian LPG has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Comparatively, Strata Critical Medical has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500.

Dorian LPG currently has a consensus price target of $42.00, suggesting a potential upside of 4.96%. Strata Critical Medical has a consensus price target of $8.00, suggesting a potential upside of 65.98%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, analysts plainly believe Strata Critical Medical is more favorable than Dorian LPG.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dorian LPG
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75

Summary

Dorian LPG beats Strata Critical Medical on 11 of the 16 factors compared between the two stocks.

How does Strata Critical Medical compare to Bristow Group?

Bristow Group (NYSE:VTOL) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap transportation companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

Bristow Group currently has a consensus price target of $60.00, suggesting a potential upside of 22.68%. Strata Critical Medical has a consensus price target of $8.00, suggesting a potential upside of 65.98%. Given Strata Critical Medical's higher probable upside, analysts plainly believe Strata Critical Medical is more favorable than Bristow Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bristow Group
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75

93.3% of Bristow Group shares are owned by institutional investors. Comparatively, 47.4% of Strata Critical Medical shares are owned by institutional investors. 13.4% of Bristow Group shares are owned by insiders. Comparatively, 15.5% of Strata Critical Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Bristow Group has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Bristow Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bristow Group$1.49B0.97$129.07M$4.3211.32
Strata Critical Medical$197.14M2.13$41.35M$0.499.84

Strata Critical Medical has a net margin of 20.97% compared to Bristow Group's net margin of 8.66%. Bristow Group's return on equity of 12.87% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Bristow Group8.66% 12.87% 5.71%
Strata Critical Medical 20.97%-5.92%-5.09%

In the previous week, Bristow Group had 9 more articles in the media than Strata Critical Medical. MarketBeat recorded 10 mentions for Bristow Group and 1 mentions for Strata Critical Medical. Bristow Group's average media sentiment score of 0.62 beat Strata Critical Medical's score of 0.00 indicating that Bristow Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bristow Group
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Strata Critical Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Bristow Group has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Strata Critical Medical has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500.

Summary

Bristow Group beats Strata Critical Medical on 10 of the 16 factors compared between the two stocks.

How does Strata Critical Medical compare to Global Ship Lease?

Strata Critical Medical (NASDAQ:SRTA) and Global Ship Lease (NYSE:GSL) are both small-cap transportation companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

Strata Critical Medical currently has a consensus price target of $8.00, suggesting a potential upside of 65.98%. Global Ship Lease has a consensus price target of $40.33, suggesting a potential downside of 2.77%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Strata Critical Medical is more favorable than Global Ship Lease.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Global Ship Lease
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67

Global Ship Lease has higher revenue and earnings than Strata Critical Medical. Global Ship Lease is trading at a lower price-to-earnings ratio than Strata Critical Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Critical Medical$197.14M2.13$41.35M$0.499.84
Global Ship Lease$766.45M1.94$416.45M$11.393.64

Global Ship Lease has a net margin of 54.33% compared to Strata Critical Medical's net margin of 20.97%. Global Ship Lease's return on equity of 22.35% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Critical Medical20.97% -5.92% -5.09%
Global Ship Lease 54.33%22.35%13.99%

Strata Critical Medical has a beta of 2.15, suggesting that its share price is 115% more volatile than the S&P 500. Comparatively, Global Ship Lease has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.

47.4% of Strata Critical Medical shares are owned by institutional investors. Comparatively, 50.1% of Global Ship Lease shares are owned by institutional investors. 15.5% of Strata Critical Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Global Ship Lease had 4 more articles in the media than Strata Critical Medical. MarketBeat recorded 5 mentions for Global Ship Lease and 1 mentions for Strata Critical Medical. Global Ship Lease's average media sentiment score of 0.91 beat Strata Critical Medical's score of 0.00 indicating that Global Ship Lease is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Strata Critical Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Global Ship Lease
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Global Ship Lease beats Strata Critical Medical on 10 of the 16 factors compared between the two stocks.

How does Strata Critical Medical compare to Navigator?

Strata Critical Medical (NASDAQ:SRTA) and Navigator (NYSE:NVGS) are both small-cap transportation companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

47.4% of Strata Critical Medical shares are owned by institutional investors. Comparatively, 19.0% of Navigator shares are owned by institutional investors. 15.5% of Strata Critical Medical shares are owned by company insiders. Comparatively, 0.4% of Navigator shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Navigator has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Navigator, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Critical Medical$197.14M2.13$41.35M$0.499.84
Navigator$586.96M2.52$100.12M$1.4815.29

Strata Critical Medical currently has a consensus price target of $8.00, suggesting a potential upside of 65.98%. Navigator has a consensus price target of $21.50, suggesting a potential downside of 4.98%. Given Strata Critical Medical's higher possible upside, research analysts clearly believe Strata Critical Medical is more favorable than Navigator.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Navigator
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Strata Critical Medical has a net margin of 20.97% compared to Navigator's net margin of 17.06%. Navigator's return on equity of 6.35% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Critical Medical20.97% -5.92% -5.09%
Navigator 17.06%6.35%3.47%

In the previous week, Navigator had 4 more articles in the media than Strata Critical Medical. MarketBeat recorded 5 mentions for Navigator and 1 mentions for Strata Critical Medical. Navigator's average media sentiment score of 0.61 beat Strata Critical Medical's score of 0.00 indicating that Navigator is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Strata Critical Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Navigator
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Strata Critical Medical has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500. Comparatively, Navigator has a beta of 0.45, suggesting that its stock price is 55% less volatile than the S&P 500.

Summary

Navigator beats Strata Critical Medical on 11 of the 17 factors compared between the two stocks.

How does Strata Critical Medical compare to Capital Clean Energy Carriers?

Capital Clean Energy Carriers (NASDAQ:CCEC) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap transportation companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

47.4% of Strata Critical Medical shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Capital Clean Energy Carriers has higher revenue and earnings than Strata Critical Medical. Capital Clean Energy Carriers is trading at a lower price-to-earnings ratio than Strata Critical Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Capital Clean Energy Carriers$392.71M2.97$170.76M$2.876.97
Strata Critical Medical$197.14M2.13$41.35M$0.499.84

Capital Clean Energy Carriers presently has a consensus price target of $24.75, indicating a potential upside of 23.75%. Strata Critical Medical has a consensus price target of $8.00, indicating a potential upside of 65.98%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, analysts clearly believe Strata Critical Medical is more favorable than Capital Clean Energy Carriers.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Capital Clean Energy Carriers
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Strata Critical Medical
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75

Capital Clean Energy Carriers has a net margin of 41.51% compared to Strata Critical Medical's net margin of 20.97%. Capital Clean Energy Carriers' return on equity of 7.85% beat Strata Critical Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Capital Clean Energy Carriers41.51% 7.85% 2.76%
Strata Critical Medical 20.97%-5.92%-5.09%

In the previous week, Capital Clean Energy Carriers had 6 more articles in the media than Strata Critical Medical. MarketBeat recorded 7 mentions for Capital Clean Energy Carriers and 1 mentions for Strata Critical Medical. Capital Clean Energy Carriers' average media sentiment score of 1.16 beat Strata Critical Medical's score of 0.00 indicating that Capital Clean Energy Carriers is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Capital Clean Energy Carriers
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Strata Critical Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Capital Clean Energy Carriers has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, Strata Critical Medical has a beta of 2.15, suggesting that its share price is 115% more volatile than the S&P 500.

Summary

Capital Clean Energy Carriers beats Strata Critical Medical on 10 of the 17 factors compared between the two stocks.

Get Strata Critical Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRTA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRTA vs. The Competition

MetricStrata Critical MedicalAir Transportation IndustryTransportation, Communications, Electric, Gas, And Sanitary SectorNASDAQ Exchange
Market Cap$419.29M$925.61M$9.99B$11.86B
Dividend YieldN/AN/A5.35%5.21%
P/E Ratio9.849.6611.3528.48
Price / Sales2.131.2631.3860.43
Price / CashN/A1.9814.0536.52
Price / Book1.501.500.956.67
Net Income$41.35M$196.61M$383.59M$332.64M
7 Day Performance-5.12%-4.97%-5.29%2.01%
1 Month Performance16.14%-0.10%10.28%9.19%
1 Year PerformanceN/AN/AN/A39.59%

Strata Critical Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRTA
Strata Critical Medical
2.2453 of 5 stars
$4.82
-1.6%
$8.00
+66.0%
N/A$419.29M$197.14M9.84130
LPG
Dorian LPG
2.2813 of 5 stars
$38.55
+0.2%
$42.00
+8.9%
N/A$1.65B$404.13M13.58540
VTOL
Bristow Group
4.818 of 5 stars
$48.63
-1.0%
$60.00
+23.4%
N/A$1.44B$1.49B11.303,660
GSL
Global Ship Lease
4.2899 of 5 stars
$39.19
-1.2%
$40.33
+2.9%
N/A$1.41B$766.45M3.447
NVGS
Navigator
3.5853 of 5 stars
$21.53
+0.7%
$21.50
-0.2%
N/A$1.40B$586.96M14.54120

Related Companies and Tools


This page (NASDAQ:SRTA) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners